Understanding how impaired signaling in eye tissues contributes to glaucoma
Impaired TRVP4-eNOS signaling in TM contributes to glaucoma
This study is looking into how problems in a specific part of the eye called the trabecular meshwork can lead to high eye pressure and glaucoma, with the hope of finding new ways to help keep your vision healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10907047 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind primary open-angle glaucoma (POAG), a leading cause of irreversible vision loss. It focuses on the trabecular meshwork (TM) tissue, which plays a crucial role in regulating intraocular pressure (IOP). The study aims to understand how dysfunction in TRPV4-eNOS signaling within the TM leads to elevated IOP and glaucoma. By exploring the effects of chronic endoplasmic reticulum stress on this signaling pathway, the research seeks to identify potential therapeutic targets to restore normal TM function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with primary open-angle glaucoma or those at risk of developing this condition.
Not a fit: Patients with other forms of glaucoma or those without any ocular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent vision loss in patients with glaucoma.
How similar studies have performed: Previous research has shown promising results in understanding the role of cellular signaling in glaucoma, indicating that this approach has potential for success.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Zode, Gulab — University of California-Irvine
- Study coordinator: Zode, Gulab
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.